Charoen Pokphand Indonesia Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Charoen Pokphand Indonesia Tbk trades at Rp3,070 (market cap 50.83T, 11.89M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume). The key difference: Charoen Pokphand Indonesia Tbk is far larger — about 321.5× Cipta Sarana Medika Tbk.'s market cap, and Charoen Pokphand Indonesia Tbk is more actively traded (11.89M versus 8.21M). Which is the better fit depends on your goals.
| CPIN | DKHH | |
|---|---|---|
Market Cap | 50.83T | 158.12B |
Volume | 11.89M | 8.21M |
Lot | 118.87K | 82.15K |
Turnover | 36.7B | 515.2M |
Average Price | 3,087.87 | 62.72 |
Value | 36.7B | 515.2M |
Indicative Equilibrium Price | 3,070 | 63 |
Indicative Equilibrium Volume | 13.65K | 1.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charoen Pokphand Indonesia Tbk (the Company) was established in Indonesia within the framework of Foreign Investment Law No. 1 year 1967 based on Notarial Deed No. 6 dated January 7, 1972 of Drs. Gde ngurah Rai, S.H. PT Charoen Pokphand Indonesia (CPI) established by CP Overseas Investment Co. Ltd., Hongkong. CPI is one of Indonesia leading agribusiness companies, with a clear focus on the formulation and production of poultry feed and the breeding of top quality poultry stock for Indonesian market. CPI is supported by expertise and experience of the established Charoen Pokphand Group of Thailand. The company has a fabrication plant, research and development facilities and breeding centers.
Read more on CPIN →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →